- Home
- PRQR vs AACB Comparison
PRQR vs AACB Comparison
Compare PRQR & AACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- AACB
- Stock Information
- Founded
- PRQR 2012
- AACB 2024
- Country
- PRQR Netherlands
- AACB United States
- Employees
- PRQR N/A
- AACB N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- AACB
- Sector
- PRQR Health Care
- AACB
- Exchange
- PRQR Nasdaq
- AACB Nasdaq
- Market Cap
- PRQR 309.5M
- AACB 276.2M
- IPO Year
- PRQR 2014
- AACB 2025
- Fundamental
- Price
- PRQR $1.69
- AACB $10.04
- Analyst Decision
- PRQR Strong Buy
- AACB
- Analyst Count
- PRQR 7
- AACB 0
- Target Price
- PRQR $9.00
- AACB N/A
- AVG Volume (30 Days)
- PRQR 573.8K
- AACB 2.4K
- Earning Date
- PRQR 05-08-2025
- AACB 01-01-0001
- Dividend Yield
- PRQR N/A
- AACB N/A
- EPS Growth
- PRQR N/A
- AACB N/A
- EPS
- PRQR N/A
- AACB N/A
- Revenue
- PRQR $21,212,711.00
- AACB N/A
- Revenue This Year
- PRQR $2.87
- AACB N/A
- Revenue Next Year
- PRQR N/A
- AACB N/A
- P/E Ratio
- PRQR N/A
- AACB N/A
- Revenue Growth
- PRQR 85.91
- AACB N/A
- 52 Week Low
- PRQR $1.07
- AACB $10.00
- 52 Week High
- PRQR $4.62
- AACB $10.25
- Technical
- Relative Strength Index (RSI)
- PRQR 56.89
- AACB N/A
- Support Level
- PRQR $1.47
- AACB N/A
- Resistance Level
- PRQR $1.82
- AACB N/A
- Average True Range (ATR)
- PRQR 0.13
- AACB 0.00
- MACD
- PRQR 0.01
- AACB 0.00
- Stochastic Oscillator
- PRQR 44.95
- AACB 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About AACB Artius II Acquisition Inc. Class A Ordinary Shares
Artius II Acquisition Inc is a blank check company.